The preeclampsia mouse model used in the in vivo study substantiated the evidence that overexpression of the Stox1 gene in the placenta induces the development of PE symptoms and brought new evidence of the direct influence of the STOX1 on the pregnancy outcome. This evidence concerns the gene STOX1 and preeclampsia.